OxRML/AgentSLR huggingface dataset:
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 1.1717 No units (Unspecified)
Exponent (base 10): 0
Statistical approach: Estimated model parameter
Reproduction number method: Other Vector-human
Trimester exposed: Unspecified
Population: Persons under investigation, sex: , ages  to 
Country: Colombia
Setting: Population based, Unspecified
Study period: 2016
Parameter: Mutations - evolutionary rate (Mutations)
Value: 8.61 Substitutions/site/year (Unspecified)
Exponent (base 10): -4
Uncertainty: 6.34 - 11.1 (HPDI 95%)
Statistical approach: Estimated model parameter
Genome site: Whole genome sequence
Population: Unspecified, sex: , ages  to 
Country: Multi-country: Africa (n = 3), Americas (n = 5), Asia (n = 6), Oceania (n = 3)
Setting: Unspecified, Unspecified
Sample size: 88
Study period: Unspecified - Aug 2018
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 0.924 No units (Unspecified)
Exponent (base 10): 0
Statistical approach: Estimated model parameter
Reproduction number method: Compartmental model Other
Trimester exposed: Unspecified
Population: General population, sex: Unspecified, ages  to 
Country: Costa Rica
Setting: Population based, Unspecified
Study period: 2016 - 2018
Parameter: Reproduction number (Basic R0) (Reproduction number)
Value: 0.737 No units (Unspecified)
Exponent (base 10): 0
Statistical approach: Estimated model parameter
Reproduction number method: Compartmental model Other
Trimester exposed: Unspecified
Population: General population, sex: Unspecified, ages  to 
Country: Suriname
Setting: Population based, Unspecified
Study period: Unspecified
Parameter: Reproduction number (Effective, Re) (Reproduction number)
Value: 1.47 No units (Unspecified)
Exponent (base 10): 0
Statistical approach: Estimated model parameter
Reproduction number method: Compartmental model Other
Trimester exposed: Unspecified
Population: General population, sex: Unspecified, ages  to 
Country: Costa Rica
Setting: Population based, Unspecified
Study period: 2016 - 2018
Parameter: Reproduction number (Effective, Re) (Reproduction number)
Value: 1.45 No units (Unspecified)
Exponent (base 10): 0
Statistical approach: Estimated model parameter
Reproduction number method: Compartmental model Other
Trimester exposed: Unspecified
Population: General population, sex: Unspecified, ages  to 
Country: Suriname
Setting: Population based, Unspecified
Study period: Unspecified
Parameter: Relative contribution - sexual (Relative contribution)
Value: 54 Percentage (%) (Unspecified)
Exponent (base 10): 0
Statistical approach: Estimated model parameter
Trimester exposed: Unspecified
Population: General population, sex: Unspecified, ages  to 
Country: Costa Rica
Setting: Population based, Unspecified
Study period: 2016 - 2018
Parameter: Seroprevalence - IgG (Seroprevalence)
Value: 89 Percentage (%) (Mean)
Exponent (base 10): 0
Numerator/denominator: 80 / 90 (method: )
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Population: Pregnant women, sex: Female, ages  to 
Country: Colombia
Location: Cereté: Córdoba state
Setting: Hospital based, Unspecified
Sample size: 90
Study period: 1 May 2016 - 31 May 2016
Parameter: Seroprevalence - IgM (Seroprevalence)
Value: 1 Percentage (%) (Mean)
Exponent (base 10): 0
Numerator/denominator: 1 / 90 (method: )
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Population: Pregnant women, sex: Female, ages  to 
Country: Colombia
Location: Cereté: Córdoba state
Setting: Hospital based, Unspecified
Sample size: 90
Study period: 1 May 2016 - 31 May 2016
Parameter: Seroprevalence - IgM (Seroprevalence)
Value: 37 Percentage (%) (Mean)
Exponent (base 10): 0
Uncertainty: 29 - 44 (95% CI)
Case definition: Lab confirmed
Numerator/denominator: 56 / 153 (method: Naive)
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: Persons under investigation, sex: Both, ages 10 to 92
Country: United States
Setting: Population based, Unspecified
Sample size: 153
Study period: Unspecified
Parameter: Seroprevalence - IgM (Seroprevalence)
Value: 0 Percentage (%) ()
Exponent (base 10): 0
Case definition: Lab confirmed
Numerator/denominator: 0 / 212 (method: Naive)
Seroprevalence adjustment: Naive
Population: General population, sex: Both, ages 23 to 86
Country: Taiwan
Location: Tainan City
Setting: Travel based, Unspecified
Sample size: 212
Study period: 2015
Parameter: Seroprevalence - IgG (Seroprevalence)
Value: 4.2 Percentage (%) (Mean)
Exponent (base 10): 0
Case definition: Lab confirmed
Numerator/denominator: 9 / 212 (method: Naive)
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: General population, sex: Both, ages 23 to 86
Country: Taiwan
Location: Tainan City
Setting: Travel based, Unspecified
Sample size: 212
Study period: 2015
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Value: 11.11 Percentage (%) (Mean)
Exponent (base 10): 0
Case definition: Lab confirmed
Numerator/denominator: 1 / 9 (method: Naive)
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: General population, sex: Both, ages 23 to 86
Country: Taiwan
Location: Tainan City
Setting: Travel based, Unspecified
Sample size: 212
Study period: 2015
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Value: 17 Percentage (%) (Central)
Exponent (base 10): 0
Numerator/denominator:  / 147 (method: Naive)
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: General population, sex: Both, ages  to 
Country: Thailand
Setting: Population based, Unspecified
Sample size: 147
Study period: 2011 - 2012
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Value: 23.5 Percentage (%) (Central)
Exponent (base 10): 0
Numerator/denominator:  / 34 (method: Naive)
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: General population, sex: Both, ages  to 
Country: Thailand
Location: Nakhon Sawan
Setting: Population based, Unspecified
Sample size: 34
Study period: 2011 - 2012
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Value: 21.6 Percentage (%) (Central)
Exponent (base 10): 0
Numerator/denominator:  / 51 (method: Naive)
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: General population, sex: Both, ages  to 
Country: Thailand
Location: Phuket
Setting: Population based, Unspecified
Sample size: 51
Study period: 2011 - 2012
Parameter: Seroprevalence - IgM (Seroprevalence)
Value: 7 Percentage (%) (Central)
Exponent (base 10): 0
Case definition: Clinically diagnosed/symptomatic;Lab confirmed
Numerator/denominator: 22 / 301 (method: Adjusted)
Seroprevalence adjustment: Adjusted
Statistical approach: Observed sample statistic
Population: Children, sex: Both, ages 0 to 14
Country: Colombia
Setting: Hospital based, Unspecified
Sample size: 301
Study period: 1 Dec 2015 - 31 Dec 2019
Parameter: Seroprevalence - IgM (Seroprevalence)
Value: 7.2 Percentage (%) (Central)
Exponent (base 10): 0
Numerator/denominator: 166 / 2293 (method: Naive)
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Population: Pregnant women, sex: Female, ages 15 to 
Country: Kenya
Location: Mombasa
Setting: Hospital based, Unspecified
Sample size: 1916
Study period: Oct 2017 - Jul 2019
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Exponent (base 10): 0
Numerator/denominator: 3 / 144 (method: Naive)
Seroprevalence adjustment: Naive
Trimester exposed: Unspecified
Population: Pregnant women, sex: Female, ages 15 to 
Country: Kenya
Location: Mombasa
Setting: Hospital based, Unspecified
Sample size: 1916
Study period: Oct 2017 - Jul 2019
Parameter: Seroprevalence - IgM (Seroprevalence)
Value: 19 Percentage (%) (Central)
Exponent (base 10): 0
Case definition: Lab confirmed
Numerator/denominator: 31 / 161 (method: Naive)
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: Persons under investigation, sex: Both, ages  to 
Country: United Kingdom
Setting: Travel based, Unspecified
Sample size: 161
Study period: 1 Jan 2016 - 31 Dec 2017
Parameter: Mutations - evolutionary rate (Mutations)
Value: 5.71 Substitutions/site/year (Unspecified)
Exponent (base 10): -3
Seroprevalence adjustment: Unspecified
Statistical approach: Estimated model parameter
Genome site: Whole genome sequence
Population: Unspecified, sex: Unspecified, ages  to 
Country: Multi-country: Pacific, Americas
Location: Pacific and Americas
Setting: Unspecified, 
Sample size: 269
Study period: 2013 - Aug 2018
Parameter: Seroprevalence - IgM (Seroprevalence)
Value: 1.7 Percentage (%) (Central)
Exponent (base 10): 0
Numerator/denominator: 6 / 349 (method: )
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Population: Pregnant women, sex: Female, ages  to 
Country: Brazil
Location: Rio de Janeiro
Setting: Hospital based, 
Sample size: 349
Study period: Jun 2017 - Dec 2017
Parameter: Seroprevalence - IgG (Seroprevalence)
Value: 46.7 Percentage (%) (Central)
Exponent (base 10): 0
Numerator/denominator: 163 / 349 (method: )
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: Pregnant women, sex: Female, ages  to 
Country: Brazil
Location: Rio de Janeiro
Setting: Hospital based, 
Sample size: 349
Study period: Jul 2017 - Dec 2017
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Value: 84 Percentage (%) (Unspecified)
Exponent (base 10): 0
Case definition: Lab confirmed
Numerator/denominator: 126 / 150 (method: Unspecified)
Seroprevalence adjustment: Unspecified
Statistical approach: Observed sample statistic
Trimester exposed: Unspecified
Population: Pregnant women, sex: Female, ages  to 
Country: Spain
Location: Hospital Universitari Vall d’Hebron Barcelona, Catalonia
Setting: Mixed settings, Unspecified
Sample size: 150
Study period: May 2016 - Dec 2021
Parameter: Reproduction number (Effective, Re) (Reproduction number)
Value: 2.13 No units (Unspecified)
Exponent (base 10): 0
Uncertainty: 2.07 - 2.19 (95% CI)
Bounds: 2.12 - 3.45
Statistical approach: Estimated model parameter
Disaggregated by: Method
Reproduction number method: Branching process Unspecified
Trimester exposed: Unspecified
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: Brazil
Location: Acre
Setting: Population based, Unspecified
Sample size: 803513
Study period: Oct 2015 - May 2016
Parameter: Attack rate (Attack rate)
Value: 0.0068634594751836 Unspecified (Unspecified)
Exponent (base 10): 0
Uncertainty: 595 - 772 (95% CI)
Bounds: 595 - 772
Numerator/denominator: 772 / 11247972 (method: )
Statistical approach: Estimated model parameter
Disaggregated by: Method
Reproduction number method:  Unspecified
Trimester exposed: Unspecified
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: Brazil
Location: Rio Grande
Setting: Population based, Unspecified
Sample size: 11247972
Study period: Oct 2015 - May 2016
Parameter: Attack rate (Attack rate)
Value: 0.0974470854858602 Unspecified (Unspecified)
Exponent (base 10): 0
Uncertainty: 772 - 925 (95% CI)
Bounds: 772 - 925
Numerator/denominator: 783 / 803513 (method: )
Statistical approach: Estimated model parameter
Disaggregated by: Method
Reproduction number method:  Unspecified
Trimester exposed: Unspecified
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: Brazil
Location: Acre
Setting: Population based, Unspecified
Sample size: 803513
Study period: Oct 2015 - May 2016
Parameter: Attack rate (Attack rate)
Value: 0.3648529387196761 Unspecified (Unspecified)
Exponent (base 10): 0
Uncertainty: 50249 - 59773 (95% CI)
Bounds: 50249 - 59773
Numerator/denominator: 55472 / 15203934 (method: )
Statistical approach: Estimated model parameter
Disaggregated by: Method
Reproduction number method:  Unspecified
Trimester exposed: Unspecified
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: Brazil
Location: Bahia
Setting: Population based, Unspecified
Sample size: 15203934
Study period: Oct 2015 - May 2016
Parameter: Attack rate (Attack rate)
Value: 0.0542505924434421 Unspecified (Unspecified)
Exponent (base 10): 0
Uncertainty: 1671 - 2364 (95% CI)
Bounds: 1671 - 2364
Numerator/denominator: 2132 / 3929911 (method: )
Statistical approach: Estimated model parameter
Disaggregated by: Method
Reproduction number method:  Unspecified
Trimester exposed: Unspecified
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: Brazil
Location: Espirito Santo
Setting: Population based, Unspecified
Sample size: 3929911
Study period: Oct 2015 - May 2016
Parameter: Attack rate (Attack rate)
Value: 0.0339299385343204 Unspecified (Unspecified)
Exponent (base 10): 0
Uncertainty: 2040 - 2578 (95% CI)
Bounds: 2040 - 2578
Numerator/denominator: 2243 / 6610681 (method: )
Statistical approach: Estimated model parameter
Disaggregated by: Method
Reproduction number method:  Unspecified
Trimester exposed: Unspecified
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: Brazil
Location: Goiania City
Setting: Population based, Unspecified
Sample size: 6610681
Study period: Oct 2015 - May 2016
Parameter: Attack rate (Attack rate)
Value: 0.6060659883398674 Unspecified (Unspecified)
Exponent (base 10): 0
Uncertainty: 12901 - 19791 (95% CI)
Bounds: 12901 - 19791
Numerator/denominator: 19791 / 3265486 (method: )
Statistical approach: Estimated model parameter
Disaggregated by: Method
Reproduction number method:  Unspecified
Trimester exposed: Unspecified
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: Brazil
Location: Mato Grosso
Setting: Population based, Unspecified
Sample size: 3265486
Study period: Oct 2015 - May 2016
Parameter: Attack rate (Attack rate)
Value: 0.0359042688993245 Unspecified (Unspecified)
Exponent (base 10): 0
Uncertainty: 3610 - 4382 (95% CI)
Bounds: 3610 - 4382
Numerator/denominator: 4008 / 11163018 (method: )
Statistical approach: Estimated model parameter
Disaggregated by: Method
Reproduction number method:  Unspecified
Trimester exposed: Unspecified
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: Brazil
Location: Panara
Setting: Population based, Unspecified
Sample size: 11163018
Study period: Oct 2015 - May 2016
Parameter: Attack rate (Attack rate)
Value: 0.1063222692613609 Unspecified (Unspecified)
Exponent (base 10): 0
Uncertainty: 9320 - 10721 (95% CI)
Bounds: 9320 - 10721
Numerator/denominator: 9936 / 9345173 (method: )
Statistical approach: Estimated model parameter
Disaggregated by: Method
Reproduction number method:  Unspecified
Trimester exposed: Unspecified
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: Brazil
Location: Pernambuco State
Setting: Population based, Unspecified
Sample size: 9345173
Study period: Oct 2015 - May 2016
Parameter: Reproduction number (Effective, Re) (Reproduction number)
Value: 1.63 No units (Unspecified)
Exponent (base 10): 0
Uncertainty: 1.58 - 1.68 (95% CI)
Bounds: 1.63 - 2.21
Statistical approach: Estimated model parameter
Disaggregated by: Method
Reproduction number method: Branching process Unspecified
Trimester exposed: Unspecified
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: Brazil
Location: Bahia
Setting: Population based, Unspecified
Sample size: 15203934
Study period: Oct 2015 - May 2016
Parameter: Reproduction number (Effective, Re) (Reproduction number)
Value: 3.05 No units (Unspecified)
Exponent (base 10): 0
Uncertainty: 2.73 - 3.41 (95% CI)
Bounds: 2.11 - 3.05
Statistical approach: Estimated model parameter
Disaggregated by: Method
Reproduction number method: Branching process Unspecified
Trimester exposed: Unspecified
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: Brazil
Location: Espirito Santo
Setting: Population based, Unspecified
Sample size: 3929911
Study period: Oct 2015 - May 2016
Parameter: Reproduction number (Effective, Re) (Reproduction number)
Value: 3.07 No units (Unspecified)
Exponent (base 10): 0
Uncertainty: 2.92 - 3.24 (95% CI)
Bounds: 1.89 - 3.33
Statistical approach: Estimated model parameter
Disaggregated by: Method
Reproduction number method: Branching process Unspecified
Trimester exposed: Unspecified
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: Brazil
Location: Goiania City
Setting: Population based, Unspecified
Sample size: 6610681
Study period: Oct 2015 - May 2016
Parameter: Reproduction number (Effective, Re) (Reproduction number)
Value: 1.67 No units (Unspecified)
Exponent (base 10): 0
Uncertainty: 1.56 - 1.79 (95% CI)
Bounds: 1.67 - 2.47
Statistical approach: Estimated model parameter
Disaggregated by: Method
Reproduction number method: Branching process Unspecified
Trimester exposed: Unspecified
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: Brazil
Location: Mato Grosso
Setting: Population based, Unspecified
Sample size: 3265486
Study period: Oct 2015 - May 2016
Parameter: Reproduction number (Effective, Re) (Reproduction number)
Value: 2.82 No units (Unspecified)
Exponent (base 10): 0
Uncertainty: 2.66 - 2.99 (95% CI)
Bounds: 1.92 - 3.12
Statistical approach: Estimated model parameter
Disaggregated by: Method
Reproduction number method: Branching process Unspecified
Trimester exposed: Unspecified
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: Brazil
Location: Panara
Setting: Population based, Unspecified
Sample size: 11163018
Study period: Oct 2015 - May 2016
Parameter: Reproduction number (Effective, Re) (Reproduction number)
Value: 1.85 No units (Unspecified)
Exponent (base 10): 0
Uncertainty: 1.75 - 1.95 (95% CI)
Bounds: 1.77 - 2.33
Statistical approach: Estimated model parameter
Disaggregated by: Method
Reproduction number method: Branching process Unspecified
Trimester exposed: Unspecified
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: Brazil
Location: Pernambuco State
Setting: Population based, Unspecified
Sample size: 9345173
Study period: Oct 2015 - May 2016
Parameter: Reproduction number (Effective, Re) (Reproduction number)
Value: 1.54 No units (Unspecified)
Exponent (base 10): 0
Uncertainty: 1.43 - 1.65 (95% CI)
Bounds: 1.54 - 2.15
Statistical approach: Estimated model parameter
Disaggregated by: Method
Reproduction number method: Branching process Unspecified
Trimester exposed: Unspecified
Population: Persons under investigation, sex: Unspecified, ages  to 
Country: Brazil
Location: Rio Grande
Setting: Population based, Unspecified
Sample size: 11247972
Study period: Oct 2015 - May 2016
Parameter: Seroprevalence - IgM (Seroprevalence)
Value: 37 Percentage (%) (Mean)
Exponent (base 10): 0
Case definition: Lab confirmed
Numerator/denominator: 41 / 112 (method: Naive)
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: Persons under investigation, sex: Unspecified, ages 0 to 0
Country: Brazil
Location: Rio de Janeiro
Setting: Population based, Unspecified
Sample size: 112
Study period: 2015 - 2016
Parameter: Mutations - substitution rate (Mutations)
Value: 1.114 Substitutions/site/year (Unspecified)
Exponent (base 10): -3
Uncertainty: 0.993 - 1.254 (HPDI 95%)
Statistical approach: Estimated model parameter
Genome site: Whole genome sequence
Genomic lineage: Asian lineage
Population: Unspecified, sex: , ages  to 
Country: Multi-country: Americas (n = 17), Asia (n = 7), Oceania (n = 3), Europe (n = 2)
Location: Global samples
Setting: Mixed settings, Unspecified
Sample size: 182
Study period: Unspecified - 1 Mar 2017
Parameter: Human delay - Onset to Admission to care (Human delay)
Value: 8 Days (Median)
Exponent (base 10): 0
Uncertainty: 4 - 21 (IQR)
Statistical approach: Observed sample statistic
Population: Persons under investigation, sex: Both, ages 3 to 92
Country: Brazil
Location: Cases acquired in travellers in Americas or Caribbean
Setting: Travel based, Unspecified
Sample size: 335
Study period: 1 Mar 2016 - 31 Dec 2019
Parameter: Seroprevalence - IgG (Seroprevalence)
Value: 6.2 Percentage (%) (Central)
Exponent (base 10): 0
Case definition: Lab confirmed
Numerator/denominator: 4 / 65 (method: Naive)
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: General population, sex: Both, ages 15 to 
Country: Mali
Location: Niono
Setting: Population based, Unspecified
Sample size: 65
Study period: Oct 2016 - Nov 2016
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Value: 3.1 Percentage (%) (Central)
Exponent (base 10): 0
Case definition: Lab confirmed
Numerator/denominator: 2 / 8 (method: Naive)
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: General population, sex: Both, ages 15 to 
Country: Mali
Location: Niono
Setting: Population based, Unspecified
Sample size: 65
Study period: Oct 2016 - Nov 2016
Parameter: Seroprevalence - IgG (Seroprevalence)
Value: 8.5 Percentage (%) (Central)
Exponent (base 10): 0
Case definition: Lab confirmed
Numerator/denominator: 11 / 129 (method: Naive)
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: General population, sex: Both, ages 15 to 
Country: Mali
Location: Bamako
Setting: Population based, Unspecified
Sample size: 129
Study period: Oct 2016 - Nov 2016
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Value: 5.4 Percentage (%) (Central)
Exponent (base 10): 0
Case definition: Lab confirmed
Numerator/denominator: 7 / 11 (method: Naive)
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: General population, sex: Both, ages 15 to 
Country: Mali
Location: Bamako
Setting: Population based, Unspecified
Sample size: 129
Study period: Oct 2016 - Nov 2016
Parameter: Seroprevalence - IgG (Seroprevalence)
Value: 10.5 Percentage (%) (Central)
Exponent (base 10): 0
Case definition: Lab confirmed
Numerator/denominator: 67 / 637 (method: Naive)
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: General population, sex: Both, ages  to 
Country: Mali
Location: Bamako
Setting: Population based, Unspecified
Sample size: 637
Study period: 2013
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Value: 7.4 Percentage (%) (Central)
Exponent (base 10): 0
Case definition: Lab confirmed
Numerator/denominator: 47 / 85 (method: Naive)
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: General population, sex: Both, ages  to 
Country: Mali
Location: Bamako
Setting: Population based, Unspecified
Sample size: 637
Study period: 2013
Parameter: Seroprevalence - IgG (Seroprevalence)
Value: 16.2 Percentage (%) (Central)
Exponent (base 10): 0
Case definition: Lab confirmed
Numerator/denominator: 22 / 136 (method: Naive)
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: General population, sex: Both, ages 15 to 
Country: Mali
Location: Kadiolo
Setting: Population based, Unspecified
Sample size: 136
Study period: Oct 2016 - Nov 2016
Parameter: Seroprevalence - Neutralisation/PRNT (Seroprevalence)
Value: 10.3 Percentage (%) (Central)
Exponent (base 10): 0
Case definition: Lab confirmed
Numerator/denominator: 14 / 23 (method: Naive)
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: General population, sex: Both, ages 15 to 
Country: Mali
Location: Kadiolo
Setting: Population based, Unspecified
Sample size: 136
Study period: Oct 2016 - Nov 2016
Parameter: Seroprevalence - IgG (Seroprevalence)
Value: 17.3 Percentage (%) (Central)
Exponent (base 10): 0
Case definition: Lab confirmed
Numerator/denominator: 22 / 127 (method: Naive)
Seroprevalence adjustment: Naive
Statistical approach: Observed sample statistic
Population: General population, sex: Both, ages 15 to 
Country: Mali
Location: Bougouni
Setting: Population based, Unspecified
Sample size: 127
Study period: Oct 2016 - Nov 2016